共 50 条
- [11] EPISTAXIS DUE TO HEREDITARY HEMORRHAGIC TELANGIECTASIA LARYNGOSCOPE, 1995, 105 (04): : 445 - 446
- [13] Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia ALLERGY & RHINOLOGY, 2014, 5 (02): : E91 - E95
- [14] Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2016, 67 (06): : 345 - 348
- [15] The Effect of Bevacizumab (Avastin) Treatment on Epistaxis in Hereditary Hemorrhagic Telangiectasia LARYNGOSCOPE, 2009, 119 (05): : 988 - 992
- [17] Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study Angiogenesis, 2021, 24 : 379 - 386
- [18] Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2019, 128 (05): : 467 - 471
- [20] Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia Orphanet Journal of Rare Diseases, 17